Affinity of doripenem and comparators to penicillin-binding proteins in Escherichia coli and Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 4, 2008, Pages 1510-1512

  Davies, Todd A ^a   Shang, Wenchi ^a   Bush, Karen ^a   Flamm, Robert K ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DORIPENEM; PENICILLIN BINDING PROTEIN; PENICILLIN BINDING PROTEIN 2; PENICILLIN BINDING PROTEIN 3; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RECEPTOR AFFINITY;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMS; CARBAPENEMS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; HUMANS; INHIBITORY CONCENTRATION 50; MICROBIAL SENSITIVITY TESTS; PENICILLIN-BINDING PROTEINS; PSEUDOMONAS AERUGINOSA;

EID: 42049110124     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01529-07     Document Type: Article

References (12)

1. Bonfiglio, G., G. Russo, and G. Nicoletti. 2002. Recent developments in carbapenems. Expert Opin. Investig. Drugs 11:529-544.
2. Brown, S. D., and M. M. Traczewski. 2005. Comparative in vitro antimicrobial activity of a new carbapenem, doripenem: tentative dise diffusion criteria and quality control. J. Antimicrob. Chemother. 55:944-949.
3. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A7, 7th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Curtis, N. A. C., D. Orr, G. W. Ross, and M. G. Boulton. 1979. Competition of β-lactam antibiotics for the penicillin-binding proteins of Pseudomonas aeruginosa, Enterobacter cloacae, Klebsiella aerogenes, Proteus rettgeri, and Escherichia coli: comparison with antibacterial activity and effects upon bacterial morphology. Antimicrob. Agents Chemother. 16:325-328.
5. Ge, Y., M. A. Wilder, D. F. Sahm, R. S. Blosser-Middleton, and J. A. Karlowsky. 2004. In vitro antimicrobial activity of doripenem, a new carbapenem. Antimicrob. Agents Chemother. 48:1384-1396.
6. Georgopapadakou, N. H. 1993. Penicillin-binding proteins and bacterial resistance to β-lactams. Antimicrob. Agents Chemother. 37:2045-2053.
7. Georgopapadakou, N. H., S. A. Smith, C. M. Cimarusti, and R. B. Sykes. 1983. Binding of monobactams to penicillin-binding proteins of Escherichia coli and Staphylococcus aureus: relation to antibacterial activity. Antimicrob. Agents Chemother. 23:98-104.
8. Hayes, M. V., and D. C. Orr. 1983. Mode of action of ceftazidime: affinity for the penicillin-binding proteins of Escherichia coli K12, Pseudomonas aeruginosa and Staphylococcus aureus. J. Antimicrob. Chemother. 12:119-126.
9. Jones, R. N., H. K. Huynh, and D. J. Biedenbach. 2004. Activities of doripenem (S-4661) against drug-resistant clinical pathogens. Antimicrob. Agents Chemother. 48:3136-3140.
10. Sifaoui, F., M.-D. Kitzis, and L. Gutmann. 1996. In vitro selection of one-step mutants of Streptococcus pneumoniae resistant to different oral β-lactam antibiotics is associated with alterations of PBP2x. Antimicrob. Agents Chemother. 40:152-156.
11. Sumita, Y., and M. Fukasawa. 1995. Potent activity of meropenem against Escherichia coli arising from its simultaneous binding to penicillin-binding proteins 2 and 3. J. Antimicrob. Chemother. 36:53-64.
12. Zhao, G., T. I. Meier, S. D. Kahl, K. R. Gee, and L. C. Blaszczak. 1999. BOCILLIN FL, a sensitive and commercially available reagent for detection of penicillin-binding proteins. Antimicrob. Agents Chemother. 43:1124-1128.